Brown Trout Management »

Apogee Therapeutics shares owned by Brown Trout Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Brown Trout Management from 13F filings

Historical chart of Brown Trout Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Brown Trout Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Brown Trout Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.8M 97k 101.00

More positions owned by Brown Trout Management

Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Chart Industries (GTLS)
Bandwidth Note 0.500% 4/0 (Principal)
Taylor Morrison Hom (TMHC)
Sabre Glbl Note 7.320% 8/0 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Veritone Note 1.750%11/1 (Principal)
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
The Realreal Note 1.000% 3/0 (Principal)
Five9 Note 1.000% 3/1 (Principal)
Shake Shack Note 3/0 (Principal)
Etsy Note 0.250% 6/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)

View all positions for Brown Trout Management

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
HBK Investments
Vanguard Capital Management
FMR
Henderson Group
Balyasny Asset Management
State Street Corporation
Driehaus Capital Management
Goldman Sachs Group
Glazer Capital
Paradigm Biocapital Advisors
Vanguard Portfolio Management
Millennium Management
Pentwater Capital Management

View all funds holding Apogee Therapeutics